Abstract:Objective: To investigate the effects of vitamin D on the malignant behavior of A549 and NCI-H1975 tumor cells (proliferation, apoptosis, invasion, metastasis and drug resistance-related proteins) and the activation of the PI3K/AKT/mTOR signaling pathway, in order to evaluate the effect of vitamin D on the therapeutic action of cisplatin. Method: In vitro cell experiments, CCK-8, flow cytometry, transwell, scratches, MTT and Western blot were used to reveal the effect of vitamin D on non-small cell lung cancer (NSCLC), and the expression of PI3K/AKT/mTOR signaling pathway was also detected. In vivo animal experiments, the nude mice were divided into four groups: control group, vitamin D treatment group, cisplatin treatment group and vitamin D + cisplatin combined treatment group. After tumor formation in vitro, tumor volume changes were calculated and tumor growth curves were drawn, collected tumor tissues for pathological sections. Western blot was used to detect the expression changes of drug-resistance related proteins in tumor tissues. Meanwhile, protein expression changes of PI3K/AKT/mTOR signaling pathway in tumor tissues were detected. Result: In vitro experiments confirm Vitamin D can inhibit the proliferation, invasion and metastasis of non-small cell lung cancer cells A549 and NCI-H1975, promoting cell apoptosis, up-regulate the sensitivity of chemotherapy drugs. These effects of vitamin D may be correlated with the PI3K/AKT/mTOR signaling pathway. In vivo animal experiments, the changes in tumor volume, tumor inflammatory infiltration range, expression of drug-resistant related proteins and signaling pathway related proteins in mice were as follows: The vitamin D and cisplatin combined treatment group was significantly smaller than the control group. Conclusion: Vitamin D can inhibit the proliferation, invasion and metastasis of non-small cell lung cancer (NSCLC) cells A549 and NCI-H1975 and promote apoptosis, up-regulate the sensitivity of chemotherapy drugs. The effect of vitamin D on NSCLC cells A549 and NCI-H1975 was correlated with the PI3K/AKT/mTOR signaling pathway. Vitamin D also promotes the therapeutic effect of CDDP.

Inhibition mechanism of vitamin D in lung cancer

Vitamin D and Lung Cancer; Association, Prevention, and Treatment

Vitamin D, Intermediary Metabolism and Prostate Cancer Tumor Progression

The Anti-cancer Actions of Vitamin D

Vitamin D Affects the Warburg Effect and Stemness Maintenance of Non-Small-Cell Lung Cancer Cells by Regulating the PI3K/AKT/mTOR Signaling Pathway

Vitamin D and lung cancer risk: a comprehensive review and meta-analysis.

Vitamin D Regulates CXCL12/CXCR4 and Epithelial-to-Mesenchymal Transition in a Model of Breast Cancer Metastasis to Lung

Vitamin D - pivotal nutraceutical in the regulation of cancer metastasis and angiogenesis.

Effect of Vitamin D on Malignant Behavior of Non-Small Cell Lung Cancer Cells.

The Anti-Inflammatory Effects of Vitamin D in Tumorigenesis

The Role of Vitamin D in Gastrointestinal Diseases: Inflammation, Gastric Cancer, and Colorectal Cancer

Mechanisms of action of vitamin D in colon cancer

Cellular and molecular effects of vitamin D on carcinogenesis

Vitamin D and Its Receptors in Cervical Cancer

Fat-soluble Vitamins and Lung Cancer: Where We Are?

1,25(OH)2D3 inhibits Lewis lung cancer cell migration via NHE1‐sensitive metabolic reprograming

Possible Molecular Mechanisms by Which Vitamin D Prevents Inflammatory Bowel Disease and Colitis-associated Colorectal Cancer.

The mechanism of calcitriol in cancer prevention and treatment.

Current progress in using vitamin D and its analogs for cancer prevention and treatment

1, 25(Oh)(2)D-3 Inhibits Hepatocellular Carcinoma Development Through Reducing Secretion Of Inflammatory Cytokines From Immunocytes

Vitamin D and regulation of vascular cell function.